Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | BMP1 | P13497 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.43 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.43 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1764514 | 1.00 | GNPAT (0.54) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL30717266 | 0.95 | GNPAT (0.57) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL2248726 | 0.95 | GNPAT (0.57) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL287577 | 0.93 | ALOX15 (0.53) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL287578 | 0.93 | ALOX15 (0.53) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL6026388 | 0.93 | ALOX15 (0.53) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL6445997 | 0.93 | ALOX15 (0.53) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL7048124 | 0.91 | ALOX15 (0.52) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL31436738 | 0.91 | ALOX15 (0.52) | GNPATALOX15BLMKDM4EMAPT | |
| SCHEMBL147914 | 0.91 | ALOX15 (0.52) | GNPATALOX15BLMKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043021-A1 | HIGH THROUGHPUT CHARACTERIZATION OF BACTERIAL PROMOTERS FROM THEIR HOST ENVIRONMENTS | UNIV CALIFORNIA (US) | 2026-02-12 | — | — | US | disclosed |
| US-8314070-B2 | Osmoprotective complexes for prevention of intra-cellular dehydration in mammals | ISLAND KINETICS, INC. (US) | 2012-11-20 | — | — | US | disclosed |
| US-8293943-B1 | Prevention of cellular senescence in mammals by natural peptide complexes | ISLAND KINETICS, INC. (US) | 2012-10-23 | — | — | US | disclosed |
| US-20120264696-A1 | PREVENTION OF CELLULAR SENESCENCE IN MAMMALS BY NATURAL PEPTIDE COMPLEXES | ISLAND KINETICS INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-8258343-B1 | Prevention of cellular senescence in mammals by natural peptide complexes | ISLAND KINETICS, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-8212076-B2 | Prevention of cellular senescence in mammals by natural peptide complexes | Covalence, Inc. (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110190202-A1 | Prevention of Cellular Senescence in Mammals by Natural Peptide Complexes | ISLAND KINETICS INC. (US) | 2011-08-04 | — | — | US | disclosed |
| US-20110124573-A1 | Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals | ISLAND KINETICS INC. (US) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124573-A1 | Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals | GLS2, GOT2, COL14A1 | GNPAT 2551/4885ALOX15 167/4885BLM 1058/4885 |
| US-20120264696-A1 | PREVENTION OF CELLULAR SENESCENCE IN MAMMALS BY NATURAL PEPTIDE COMPLEXES | COL14A1, TP53, CUTA | GNPAT 3243/4885ALOX15 1107/4885BLM 436/4885 |
| US-20260043021-A1 | HIGH THROUGHPUT CHARACTERIZATION OF BACTERIAL PROMOTERS FROM THEIR HOST ENVIRONMENTS | CTCF, PURB, MRPL21 | GNPAT 3071/4885ALOX15 4883/4885BLM 882/4885 |
| US-20110190202-A1 | Prevention of Cellular Senescence in Mammals by Natural Peptide Complexes | COL14A1, TP53, CUTA | GNPAT 3243/4885ALOX15 1107/4885BLM 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.